Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Porcellati, F.
Right arrow Articles by et, al.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porcellati, F.
Right arrow Articles by et, al.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 42, Issue 7 1055-1064, Copyright © 1993 by American Diabetes Association


ARTICLES

Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy

F Porcellati, C Fanelli, P Bottini, L Epifano, AM Rambotti, C Lalli, S Pampanelli, L Scionti, F Santeusanio, P Brunetti and al. et
Institute of Internal Medicine, University of Perugia, Italy.

To assess whether a therapeutic, subcutaneous injection of insulin exerts hemodynamic effects in subjects with IDDM, 0.2 U/kg regular insulin was injected subcutaneously in 17 IDDM subjects: 6 without autonomic neuropathy, 7 with autonomic neuropathy and othostatic hypotension, and 4 with autonomic neuropathy but without orthostatic hypotension. Plasma glucose was maintained at approximately 8.5 mM throughout the studies. Mean blood pressure, plasma norepinephrine concentration, forearm vascular resistances, and calf venous volume were measured before and 120 min after subcutaneous insulin, in the supine position and 5 min after standing. Supine plasma volume ([125I]albumin and [131I]albumin) was measured before and after subcutaneous injection of insulin. In all three groups, subcutaneous insulin activated the sympathetic nervous system (approximately 30% increase in norepinephrine concentration). In subjects with IDDM but without autonomic neuropathy, standing forearm vascular resistance increased approximately 70% less after subcutaneous insulin, but supine or standing mean blood pressure did not decrease. In contrast, in subjects with IDDM with autonomic neuropathy and orthostatic hypotension, subcutaneous insulin decreased supine mean blood pressure (from 99 +/- 3 to 94 +/- 5 mmHg) and exaggerated the standing decrement in mean blood pressure (24 +/- 3 vs. 19 +/- 2 mmHg) (P < 0.05). This was associated with a decrease in forearm vascular resistance. Similarly, in subjects with IDDM with autonomic neuropathy without orthostatic hypotension, subcutaneously injected insulin decreased supine mean blood pressure (from 95 +/- 2 to 89 +/- 2 mmHg) and standing mean blood pressure by 8 +/- 1 mmHg (P < 0.05). Calf venous volume was not affected by subcutaneous insulin in any of the three groups. Plasma volume did not change after subcutaneous insulin in subjects with IDDM without autonomic neuropathy, whereas it decreased in those with autonomic neuropathy and orthostatic hypotension from 1.692 +/- 0.069 to 1.610 +/- 0.064 L/m2, without orthostatic hypotension from 1.631 +/- 0.027 to 1.593 +/- 0.024 L/m2, P < 0.05). No hemodynamic effects were observed when subjects with IDDM were restudied in a control experiment where placebo (distilled water), not insulin, was injected subcutaneously. In conclusion, therapeutic doses of subcutaneous insulin activate the sympathetic nervous system; decrease blood pressure in subjects with IDDM with autonomic neuropathy, but not in those without, primarily by decreasing arterial vascular resistances and plasma volume; and have no effects of capacitance vessels. Thus, in subjects with IDDM without autonomic neuropathy, greater activation of sympathetic nervous system after subcutaneous injection of insulin prevents orthostatic hypotension.(ABSTRACT TRUNCATED AT 400 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eur Respir JHome page
P. Bottini, M.L. Dottorini, M. Cristina Cordoni, G. Casucci, and C. Tantucci
Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy
Eur. Respir. J., October 1, 2003; 22(4): 654 - 660.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. Tantucci, P. Bottini, C. Fiorani, M. L. Dottorini, F. Santeusanio, L. Provinciali, C. A. Sorbini, and G. Casucci
Cerebrovascular reactivity and hypercapnic respiratory drive in diabetic autonomic neuropathy
J Appl Physiol, March 1, 2001; 90(3): 889 - 896.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
G. R. McAnulty, H. J. Robertshaw, and G. M. Hall
Anaesthetic management of patients with diabetes mellitus
Br. J. Anaesth., July 1, 2000; 85(1): 80 - 90.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P J Watkins and P K Thomas
Diabetes mellitus and the nervous system
J. Neurol. Neurosurg. Psychiatry, November 1, 1998; 65(5): 620 - 632.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Mäkimattila, M. Mäntysaari, A. Schlenzka, and P. S. H. Yki-Järvinen
Mechanisms of Altered Hemodynamic and Metabolic Responses to Insulin in Patients with Insulin-Dependent Diabetes Mellitus and Autonomic Dysfunction
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 468 - 475.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1993 by the American Diabetes Association.